Hutchison China Meditech Limited
575
0 Kommentare
Sulfatinib Phase II Study in 2nd Line BTC in China - Seite 4
575 
0 KommentareCONTACTS
| Investor Enquiries | ||||
| Christian Hogg, CEO | +852 2121 8200 | |||
| International Media Enquiries | ||||
|
Anthony Carlisle, Citigate Dewe Rogerson |
+44 7973 611 888 (Mobile) | anthony.carlisle@cdrconsultancy.co.uk | ||
| U.S. Based Media Enquiries | ||||
| Brad Miles, BMC Communications | +1 (917) 570 7340 (Mobile) | bmiles@bmccommunications.com | ||
| Susan Duffy, BMC Communications | +1 (917) 499 8887 (Mobile) | sduffy@bmccommunications.com | ||
| Investor Relations | ||||
| Matt Beck, The Trout Group | +1 (917) 415 1750 (Mobile) | mbeck@troutgroup.com | ||
| David Dible, |
Lesen Sie auch
Aktuelle Themen
Verfasst von Marketwired
URL kopieren
Per E-Mail teilen
Artikel drucken1 im Artikel enthaltener WertIm Artikel enthaltene Werte
Artikel zu den Werten
Auch bei Lesern beliebt
